INH: Standing Between You and Tuberculosis
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
Author:
Florida Department of Health, Florida Department of Health, Bureau of TB and Refugee Health
Audiences:
Asian or Pacific Islander persons, Non-U.S.-born persons, Persons With LTBI
Topic:
Treatment- Patient Adherence, Treatment- Adverse Reactions, Treatment - Latent TB infection (Inactive TB), Treatment- Medication Information
Country of Origin:
United States
Global resources for the prevention,
management, and elimination of TB.